Publications
-
May 31, 2017
Development of a Harmonized Patient-Reported Outcome Questionnaire to Assess Myelofibrosis Symptoms in Clinical Trials
Gwaltney C, Paty J, Kwitkowski VE, Mesa RA, Dueck AC, Papadopoulos EJ, Wang L, Feliciano J, Coons SJ. Development of a Harmonized Patient-Reported Outcome Questionnaire to Assess Myelofibrosis Symptoms in Clinical Trials. Leukemia Research. 2017;59:26–31. - May 16, 2017
-
May 1, 2017
Tuberculosis and Antimicrobial Resistance – New Models of Research and Development Needed
Brigden G, Castro JL, Ditiu L, Gray G, Hanna D, Low M, Matsoso MP, Perry G, Spigelman M, Swaminathan S, Torreele E, Wong S. Tuberculosis and Antimicrobial Resistance – New Models of Research and Development Needed. Bulletin of the World Health Organization. 2017 May 1;95(5):315.
-
April 20, 2017
Development of the Diary for Irritable Bowel Syndrome Symptoms (DIBSS) to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research
Fehnel S, Ervin C, Carson R, Rigoni G, Lackner J, Coons SJ, et al. Development of the Diary for Irritable Bowel Syndrome Symptoms (DIBSS) to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research. Value in Health. 20(4):618–26.
-
April 1, 2017
Response of Novel Skeletal Muscle Biomarkers in Dogs to Drug-Induced Skeletal Muscle Injury or Sustained Endurance Exercise
Vlasakova, Katerina, Pamela Lane, Laura Michna, Nagaraja Muniappa, Frank D. Sistare, and Warren E. Glaab. “Response of Novel Skeletal Muscle Biomarkers in Dogs to Drug-Induced Skeletal Muscle Injury or Sustained Endurance Exercise.” Toxicological Sciences: An Official Journal of the Society of Toxicology 156, no. 2 (April 1, 2017): 422–27.
